Clinical Trial Update: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety trial of RPT193 in adults with atopic dermatitis was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• RPT193

Snippet

Sponsor: RAPT Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED | Results posted: 2026-02-25